Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus erythematosus (SLE) have been revealed, and have not disappointed.

We recently compiled a list of the 11 Best Pharma Stocks to Invest in for the Long Term. ANI Pharmaceuticals, Inc. is one of them. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP), a specialty pharmaceutical ...

Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team: Catalysis offers the prospect of low energy, ...

A Phase 2, Adaptive, Randomized, Open-label, Assessor-blinded Active-controlled Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Standard of Care in Patients Suffering From ...